The Unitary Micro-Immunotherapy Medicine Interferon-γ (4 CH) Displays Similar Immunostimulatory and Immunomodulatory Effects Than Those of Biologically Active Human Interferon-γ on Various Cell Types
Overview
Chemistry
Molecular Biology
Affiliations
As a cytokine, gamma-interferon (IFN-γ) is considered a key player in the fine-tuned orchestration of immune responses. The extreme cellular sensitivity to cytokines is attested by the fact that very few of these bioactive molecules per cell are enough to trigger cellular functions. These findings can, at least partially, explain how/why homeopathically-prepared cytokines, and especially micro-immunotherapy (MI) medicines, are able to drive cellular responses. We focused our fundamental research on a unitary MI preparation of IFN-γ, specifically employed at 4 CH, manufactured and impregnated onto sucrose-lactose pillules as all other MI medicines. We assessed the IFN-γ concentration in the medium after dilution of the IFN-γ (4 CH)-bearing pillules and we evaluated in vitro drug responses in a wide range of immune cells, and in endothelial cells. Our results showed that IFN-γ (4 CH) stimulated the proliferation, the activation and the phagocytic capabilities of primary immune cells, as well as modulated their cytokine-secretion and immunity-related markers' expression in a trend that is quite comparable with the well-recognized biological effects induced by IFN-γ. Altogether, these data provide novel and additional evidences on MI medicines, and specifically when active substances are prepared at 4 CH, thus suggesting the need for more investigations.
Exploring the Potential of Micro-Immunotherapy in the Treatment of Periodontitis.
Ferra-Canellas M, Garcia-Sureda L Life (Basel). 2024; 14(5).
PMID: 38792574 PMC: 11122531. DOI: 10.3390/life14050552.
Jacques C, Marchand F, Chatelais M, Albinet V, Coustal C, Floris I Cancers (Basel). 2024; 16(7).
PMID: 38611099 PMC: 11010933. DOI: 10.3390/cancers16071421.
In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy.
Jacques C, Marchand F, Chatelais M, Brulefert A, Riffault M, Floris I Life (Basel). 2024; 14(3).
PMID: 38541700 PMC: 10971188. DOI: 10.3390/life14030375.
Jacques C, Marchand F, Chatelais M, Floris I J Inflamm Res. 2024; 17:1161-1181.
PMID: 38406323 PMC: 10894519. DOI: 10.2147/JIR.S445053.
Jacques C, Marchand F, Chatelais M, Brulefert A, Floris I Life (Basel). 2024; 14(1).
PMID: 38255717 PMC: 10821216. DOI: 10.3390/life14010102.